المجلة الدولية للعلوم والتقنية

Aims. the present study was undertaken to estimate the relation between different useable antidiabetic drug to HbA1c control among diabetic patients in Albayda city, Libya. Method. This study was conducted to interviewed 200 patients diagnosed with type 2 diabetes at main center for diabetes treatment in the Al-bayda city during period from April 2023 to August 2023 . Several parameters were detected, including age, sex, levels of (FBS, HBA1C), hypertension and name of antidiabitic drug Of 200 patients. Result., 66% (n=132) , 34% (n=68) were female and male respectively, the mean age of 55 years (31-80) , The most diabetes patient age group was (51-60) years old followed by (61-70) years old (40.5% and 23.5% of the subjects). Around 51% of patients had diabetes less than five years ago. Hypertension was present in 41% of male and 49.5% of female subjects. Six antidiabitic drugs were studied, metformin is regarded as the drug of choice for most patients with type 2 diabetes, about 30% using it as single drug and 24.5% in combination with glyburide Conclusion combined metformin with other oral antidiabetic drugs as Amaryl and Gliburide was the better glycemic control than when using metformin alone. Keywords: Diabetes mellitus, oral antidiabitic drugs, Hypertesion, weight.